The best indicator for DaVita (DVA)
We backtested 366 indicators across daily, weekly and hourly charts on real DaVita (DVA) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
ADXR
On the weekly chart, this is the strongest risk-adjusted edge we found for DaVita (DVA) over ~30.7 years — trailing buy-and-hold by 0.3% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for DaVita (DVA) — trailing buy-and-hold by 10.1% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | ADXR ✓ | Weekly | 13.1% | 0.65 | -44.2% | 63.6% | 44 | -0.3% |
| 2 | VIDYA 10/30 Cross ✓ | Daily | 13.0% | 0.6 | -55.9% | 41.9% | 31 | -0.5% |
| 3 | McGinley 30 Trend ✓ | Daily | 17.0% | 0.6 | -83.9% | 41.7% | 24 | 3.6% |
| 4 | ADX / DMI ✓ | Weekly | 12.0% | 0.6 | -51.1% | 51.3% | 39 | -1.4% |
| 5 | Predictive Ranges ✓ | Daily | 12.9% | 0.6 | -49.0% | 37.6% | 290 | -0.5% |
| 6 | SMC: Fair Value Gap ✓ | Weekly | 13.3% | 0.59 | -58.2% | 52.3% | 65 | -0.1% |
| 7 | Momentum ✓ | Weekly | 12.7% | 0.58 | -42.9% | 50.9% | 110 | -0.7% |
| 8 | Bandpass Oscillator ✓ | Weekly | 13.2% | 0.58 | -36.9% | 61.5% | 78 | -0.2% |
| 9 | ROC (10) ✓ | Weekly | 12.7% | 0.58 | -42.9% | 50.9% | 110 | -0.7% |
| 10 | Momentum (10) ✓ | Weekly | 12.7% | 0.58 | -42.9% | 50.9% | 110 | -0.7% |
| 11 | Ultimate Osc (4,8,16) ✓ | Daily | 13.6% | 0.57 | -58.5% | 44.8% | 755 | 0.1% |
| 12 | HalfTrend ✓ | Weekly | 12.6% | 0.57 | -59.2% | 51.4% | 35 | -0.8% |
| 13 | MAMA / FAMA ✓ | Weekly | 12.3% | 0.57 | -39.4% | 51.6% | 31 | -1.1% |
| 14 | McGinley 100 Trend ✓ | Daily | 15.5% | 0.59 | -81.2% | 28.6% | 14 | 2.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For DaVita (DVA), ADXR on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.